HZOMarineMax, Inc.
Is the price fair?
Neither cheap nor expensive: nothing decisive, though modest expectations priced in.
Priced for a decline (~−10% a year). Little growth is priced in even as revenue fell 2% a year over three years, potential value, or a value trap.
In its normal range: P/E 8.8 vs a 9.3 median over 36 quarters (−5% vs median).
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What HZO's price assumes
MarineMax, Inc. trades at 404× earnings against 22.8× for the median Specialty Retail name, more expensive than its own group.
Trailing P/E · Specialty Retail median 22.8 · 17.8× the median: the market pays up for this one
- Price / sales
- 0.39
Price / sales · as of 2026-Q2
- Free cash flow yield
- 15%
Free cash flow yield · Specialty Retail median 5.5%
- Growth the price implies
- −9.6%
Growth the price implies · The price pays for −9.6% free cash flow growth a year for a decade; revenue has shrunk 2.1% a year over the last three.
Details›
- Price / bookas of 2026-Q2
- 0.89
- EV / EBITas of 2026-Q2
- 24.6
- EV / salesas of 2026-Q2
- 0.75
- Consumer Cyclical median P/E317 names
- 18.0
- Specialty Retail median P/E25 names
- 22.8
- Free cash flow, trailing twelve months
- $178M
- Market capitalisation22.1 million shares, counted Jul 20, 2026
- $1.16B
- 3-year revenue growth
- −2.1%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $0.97 |
| Its own P/E history, median | $1.21 |
| Its own P/E history, upper quartile | $1.83 |
| 52-week range | $21.43 – $52.56 |
| Today | $52.56 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
What is it worth?
Today's price against what its own multiples, its cash flow and your growth assumption say it is worth.
Against its own past
Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.